Sanofi
Sanofi under investigation for anti-competitive practices
May 20, 2010Sales and Marketing Plavix, Sanofi
Sanofi-Aventis is to be investigated by the French Competition Authority for anti-competitive practices, following allegations it prevented the launch of …
Sanofi-Aventis signs drug with potential to reverse diabetes
April 9, 2010Research and Development Sanofi, diabetes
Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …
Warner Chilcott gets Actonel lift
April 6, 2010Sales and Marketing Sanofi, Warner Chilcott, actonel, osteoporosis
Warner Chilcott has assumed all commercial responsibility for its osteoporosis drug Actonel in the US. Sanofi-Aventis has agreed to pass …
Sanofi and Merck to merge animal health businesses
March 9, 2010Sales and Marketing Merck, Sanofi, animal health
Sanofi-Aventis and Merck have announced a joint venture, bringing together their animal health businesses Merial and Intervet/Schering-Plough. The company’s say …
Sanofi’s BSI-201 tipped for success in triple negative breast cancer
February 28, 2010Sales and Marketing Cancer, PARP, Sanofi, breast cancer
Sanofi-Aventis’s BSI-201 will garner sales of $1.7 billion in the triple negative breast cancer drug market in 2018, according to …
Lancet retracts MMR research conclusions
February 3, 2010Research and Development MMR, Sanofi, vaccines
The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …
Sanofi Pasteur collaborates on novel biologics
January 12, 2010Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines
Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …
NICE says no to Multaq
January 8, 2010Sales and Marketing Multaq, NICE, Sanofi
NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …
Sanofi bags consumer healthcare specialist Chattem
January 5, 2010Chattem, OTC, Sanofi
Sanofi-Aventis looks set to become much bigger in over-the-counter pharmaceuticals with a $1.9 billion agreement to buy US company Chattem. …
Sanofi pulls out of Dagenham
December 21, 2009Manufacturing and Production Essex, Sanofi, closure
The UK stands to lose one of its flagship pharmaceutical manufacturing facilities with the recent announcement that Sanofi-Aventis’ site in …
Sanofi’s Plavix combination recommended for European approval
December 21, 2009Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux
Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
Sanofi expands antibody venture with Regeneron
November 12, 2009Research and Development Regeneron, Sanofi
Sanofi-Aventis has put more financial muscle behind its partnership with Regeneron for the development of monoclonal antibody-based drugs, boosting its …
Sanofi says its H1N1 jab effective after one dose
October 2, 2009Sales and Marketing Sanofi, h1n1
Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, has said its swine flu vaccine is effective after a single …
Sanofi-Aventis acquires French biotech Fovea
October 1, 2009Sales and Marketing Sanofi, ophth
Sanofi-Aventis is to acquire Fovea Pharmaceuticals, a privately held French company with a focus on diseases of the eye.Fovea has …
Sanofi on track to deliver flu vaccine
September 30, 2009Sales and Marketing Sanofi, h1n1
French company Sanofi-Pasteur is on track to deliver its H1N1 flu vaccine over the next two months, chief executive Chris …
Latest content
Five Facts about cardiovascular disease
